GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (STU:Z45) » Definitions » Total Receivables

Alvotech (STU:Z45) Total Receivables : €66.6 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Total Receivables?

Alvotech's Total Receivables for the quarter that ended in Mar. 2024 was €66.6 Mil.


Alvotech Total Receivables Historical Data

The historical data trend for Alvotech's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Total Receivables Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Receivables
- 31.98 47.69 67.39 79.98

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.21 45.64 39.40 79.98 66.56

Alvotech Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Alvotech Total Receivables Related Terms

Thank you for viewing the detailed overview of Alvotech's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Alvotech (STU:Z45) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Alvotech (STU:Z45) Headlines

No Headlines